ARCHIVES

FDA Approves Inlyta Pill For Renal Cell Carcinoma

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

Research Funding: 30 Groups Sign Letter For Double NCI Budget

January 23, 1998

FDA News: Tentative Approval Given IVAX Paxene; BMS Exclusivity Upheld

January 9, 1998

Supplements Reduce Deaths In NCI Studies In China “JNCI”

September 17, 1993

Lasofoxifene Reduced Breast Cancer Risk In Postmenopausal Osteoporotic Women

November 26, 2010

FDA Grants Accelerated Approval To Mekinist-Tafinlar Combination

January 31, 2014

In Brief: Administration Ignores Congressional Mandate To Revive Training Grants, Funds Fellowships

February 8, 1974